Harvard Bioscience, Inc., a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, has acquired the business of AHN Biotechnologie GmbH through a subsidiary of its wholly owned Biochrom Ltd. subsidiary.

Starting in March 2012, the internationally renowned customs law expert Michael Lux will strengthen Graf von Westphalen's foreign trade law team led by Lothar Harings and Marian Niestedt. He will be based in the law firm's Brussels office.

Graf von Westphalen (GvW) will open a new office in Düsseldorf in April 2012, making it one of only a few major independent law firms in Germany to have a presence in all key economic regions of the country.

On December 29, 2011 Jeco Pte Ltd. with registered offices in Singapore, has completed the acquisition of a 49%-interest in Braun GmbH & Co.KG.

Graf von Westphalen is proud to welcome yet another high-caliber member to our team: As of 01 January 2012, Dr. Werner Schnappauf will be working for our partnership of lawyers. Between 1998 and 2007, the CSU politician was the Bavarian Minister of State, initially in charge of urban and regional development and environmental issues and then responsible for environmental, public health and consumer protection issues.

Dominik Ziegenhahn, partner in the Hamburg office of Graf von Westphalen and specializing in corporate law, has been appointed Vice President of the Board of the Chinese European Legal Association e. V. ("CELA"). He was elected to this position by the members of CELA in December 2011.

AAR CORP. (NYSE: AIR) with registered offices in Wood Dale, Illinois has completed the acquisition of Telair International GmbH and Nordisk Aviation Products, AS from Teleflex International (NYSE: TFX) on December 2, 2011. The transaction value amounted to about USD 280 million.

Graf von Westphalen has once again received strong endorsements in the JUVE Handbook. In the latest edition 2011/2012, the leading guide to commercial law firms in Germany recommends Graf von Westphalen as one of the top law firms in the areas of trade, commercial/M&A, real-estate law, environmental and planning law as well as state-aid and public-procurement law.

The Graf von Westphalen law firm held its partners' meeting on November 11 and 12, 2011. In addition to many issues, the meeting's agenda included a number of elections.

Graf von Westphalen together with HHP Attorneys-At-Law has advised Lonza Group Ltd. ("Lonza"), one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries based in Basel, Switzerland and listed on the Six Swiss Exchange, on the PRC legal aspects of its successful secondary listing on the Singapore Exchange Securities Trading Limited ("SGX-ST").